gms | German Medical Science

21. Jahrestagung der Retinologischen Gesellschaft gemeinsam mit dem
8. Symposium der International Society of Ocular Trauma

Deutsche Gesellschaft für Retinologie
International Society of Ocular Trauma

19.06. - 22.06.2008, Würzburg

A brief review on international guidelines for screening and therapy of acute retinopathy of prematurity

Meeting Abstract

Suche in Medline nach

  • Heinrich Gerding - Olten/Schweiz

Retinologische Gesellschaft. International Society of Ocular Trauma. 21. Jahrestagung der Retinologischen Gesellschaft gemeinsam mit dem 8. Symposium der International Society of Ocular Trauma. Würzburg, 19.-22.06.2008. Düsseldorf: German Medical Science GMS Publishing House; 2008. DocISOTRG2008V135

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 18. Juni 2008

© 2008 Gerding.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



For many years the CRYO-ROP study result was the international gold standard for the organization of ROP screening and therapy in paediatric units with a highly developed standard of perinatal care of premature babies. The publication of the ETROP study (Early treatment of Retinopathy of Prematurity) has led to a recommended expansion of the therapy indication including children with prethreshold disease when the following criteria are met: 1. plus-disease or stage 3 in zone I, 2. stage 2+ or 3+ in zone II. When comparing the recently published guidelines for the screening and therapy of ROP in the United States, United Kingdom and Germany it becomes obvious that different interpretations of the ETROP results were implemented in the construction of guidelines. One of the most striking differences in the published recommendations is the fact that the recently published German guidelines do not adhere to the concept of expanded indication for active intervention on children with zone II retinopathy at stage 2+ or 3+. The reason for a different view is obviously a variant interpretation of the complex statistics of the ETROP study results. The community of ophthalmologists actively dealing with premature children should be aware about the differences in current data interpretation and the possible application in the practical care for premature babies.